Study of the Aorta Adaptations to Exercise in Triathletes During Sports Season (CoATri)

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Completed
CT.gov ID
NCT03356301
Collaborator
(none)
63
1
2
15.2
4.2

Study Details

Study Description

Brief Summary

Regular sustained physical activity creates a cardiac remodelling : it is athlete's heart. In our preliminary work published in 2016, the investigators demonstrated in a small population of triathletes that there is also a vascular remodelling named athlete's artery. Moreover, the investigators know that left ventricle and aorta behave together like a couple. So they want to study by Cardiovascular Magnetic Resonance Imaging the impact of triathlon on the cardiac AND aortic remodelling.

Condition or Disease Intervention/Treatment Phase
  • Device: Cardiac MRI
  • Device: Applanation tonometry
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
63 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Study of the Remodeling of the Ascending Aorta During the Sports Season in Long Distance Triathletes Versus Controls
Actual Study Start Date :
Dec 1, 2017
Actual Primary Completion Date :
Mar 8, 2019
Actual Study Completion Date :
Mar 8, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Triathletes

Every triathlete will realize three cardiac MRI exams.The second of those will be done at the fitness peak, 2-3 weeks before the main objective of the sports season. Training will be increased between the study beginning and the first MRI, and the second exam. After each cardiac MRI, an applanation tonometry examination will aslo be performed.

Device: Cardiac MRI
Non injected cardiac MRI exam

Device: Applanation tonometry
Applanation tonometry and ECG

Experimental: Controls

Every control subject will also realize three cardiac MRI exams if possible at the same time as the triathletes.They must be not engaged in physical activity more than 150 minutes a week on average. After each cardiac MRI, an applanation tonometry examination will aslo be performed.

Device: Cardiac MRI
Non injected cardiac MRI exam

Device: Applanation tonometry
Applanation tonometry and ECG

Outcome Measures

Primary Outcome Measures

  1. Aortic compliance in triathletes in mm2/mmHG [at baseline, at the fitness peak (6 to 10 months later) and at recovery (3 to 6 months after the fitness peak)]

    aortic compliance = pulsed pressure-to-absolute variation of aortic surface ratio

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 39 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • to be enrolled in a social security plan.

  • to have a BMI between 18,5 and 25 kg/m²

  • to have received full information on the organization of the research and having signed its informed consent

  • to have carried out a clinical screening adapted to the research

*** Triathlete group:

  • to have a minimum performance level: between 2h and 2h45 on an M triathlon during the past year (provide proof),

  • to participate in 2018 in a long distance triathlon, i. e. at least distance L

  • to have a defined training volume: less than 8 hours per week during the winter months and between 10 and 15 hours per week in preparation of the objective

***Control group:

  • to have no more than 150 minutes of moderate physical activity per week (footing, brisk walking, cycling, etc.).
Exclusion Criteria:
  • Persons referred to in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public Health Code

  • Cardiovascular history including Ii.e. known heart rhythm disorders

  • Chronic disease: diabetes, high blood pressure...

  • Long-term drug therapies that may modify cardiovascular remodeling such as Conversion Enzyme Inhibitor, Angiotensin II Receptor Antagonist,

  • Active smoking, even if occasional

  • Contraindication to MRI

Contacts and Locations

Locations

Site City State Country Postal Code
1 Central Hospital Nancy France 54000

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Principal Investigator: Damien MANDRY, MD,PhD, CHRU de Nancy
  • Principal Investigator: Anne-Charlotte DUPONT, MD, CHRU de Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT03356301
Other Study ID Numbers:
  • 2017-A01872-51
First Posted:
Nov 29, 2017
Last Update Posted:
Feb 11, 2020
Last Verified:
Jan 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 11, 2020